Catalent
CTLT
#1585
Rank
NZ$18.31 B
Marketcap
$100.92
Share price
-0.17%
Change (1 day)
79.37%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$10.52 Billion

According to Catalent's latest financial reports the company's total liabilities are NZ$10.52 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30NZ$10.16 B10.36%
2022-06-30NZ$9.20 B33.06%
2021-06-30NZ$6.92 B4.16%
2020-06-30NZ$6.64 B14.66%
2019-06-30NZ$5.79 B13.95%
2018-06-30NZ$5.08 B36.14%
2017-06-30NZ$3.73 B8.4%
2016-06-30NZ$3.44 B-5.88%
2015-06-30NZ$3.66 B-7.18%
2014-06-30NZ$3.94 B-9.08%
2013-06-30NZ$4.33 B-0.22%
2012-06-30NZ$4.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$0.57 B-94.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.92 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.79 B 31.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$0.54 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA